Post-Stroke Dysphagia
Conditions
Interventions
control group:Basic drug therapy, rehabilitation therapy, neuromuscular electrical stimulation
observation group:Basic drug therapy, rehabilitation therapy, Yuyin Qianyang Acupuncture
Sponsors
Xiamen Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Meet the aforementioned diagnostic criteria for stroke in both Western medicine and Traditional Chinese Medicine (TCM). First-time stroke onset, with a disease course between 2 weeks and 1 year. Meet the aforementioned diagnostic criteria for dysphagia, with imaging findings (CT/MRI) confirming unilateral supratentorial infarction or hemorrhage. Medically stable condition and able to cooperate with all required examinations. Aged between 35 and 80 years, regardless of gender. Able to cooperate with acupuncture and related treatments. Both the patient and their family voluntarily agree to participate in this study and have signed the informed consent form approved by the Institutional Review Board (IRB)/Ethics Committee. Not concurrently participating in any other clinical trials.
Exclusion criteria
Exclusion criteria: Patients with large-area damage to one side of the corpus callosum caused by cerebral infarction or hemorrhage. Patients with comorbid impaired consciousness or psychiatric disorders; or those with a history of or active epileptic seizures; or those exhibiting emotional agitation, aggression, or disruptive behavior that would preclude cooperation with acupuncture treatment. Patients with acute infectious diseases, severe diabetes mellitus, organic pathologies of the cardiovascular, hepatic, renal, or other major organ systems, hematopoietic system diseases, endocrine disorders, or malignant tumors; or those with unstable vital signs. Dysphagia attributable to other causes, such as oral or head/neck tumors, musculoskeletal disorders, Parkinson's disease, refusal to eat due to impaired consciousness or dietary paranoia/aversion. Patients with a known allergy to contrast agents (used in VFSS), electrode patches (used in electrical stimulation therapy), or conductive gel. Patients with skin ulceration, infection, or allergic conditions at the proposed acupuncture sites. Patients who are pregnant or lactating. Patients with cranial defects or the presence of intracranial metallic implants (e.g., cochlear implants, intracranial stimulators, pacemakers, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the Rosenbek Penetration-Aspiration Scale (PAS) score via Videofluoroscopic Swallow Study (VFSS); | — |
Secondary
| Measure | Time frame |
|---|---|
| electroencephalography (EEG);motor evoked potentials (MEP);cortical silent period (CSP); | — |
Countries
The People's Republic of China
Contacts
Public ContactYanxun Huang
Xiamen Hospital of Traditional Chinese Medicine
Outcome results
None listed